stockrow
Saturday 7 November 2026
Export DCGO’s income statement to Excel — free account
DocGo Inc.
DCGO Healthcare Medical Care Facilities
DocGo Inc.’s revenue for fiscal 2025 (year ended December 2025) was $322.2 million, down 47.7% from fiscal 2024.
- Revenue
- −8.70%
- EPS
- −45.5%
- Free cash flow
- −132.3%
- Total debt
- +7,140.9%
Quarter to June 2026, against a year earlier
0.25
0.01
+4.17%
Follow DCGO
Alert me
| Older periods | Sep '25 | Dec '25 | Mar '26 | Jun '26 | |
|---|---|---|---|---|---|
Piotroski F-Score |
+8 more TTM periods Free account |
4 | 3 | 3 | 3 |
| (17.62%) | (82.71%) | (90.89%) | (100.35%) | ||
| (12.17%) | (54.23%) | (58.67%) | (64.67%) | ||
ROIC |
(26.98%) | (148.29%) | (150.87%) | (161.93%) | |
Return on Tangible Assets |
(39.40%) | (183.38%) | (251.73%) | (319.77%) | |
Average Days of Receivables |
106.12 | 105.23 | 113.68 | 106.78 | |
Free Cash Flow per Share |
0.53 | 0.27 | 0.14 | (0.29) | |
Free Cash Flow |
52.13 | 27.22 | 13.92 | (28.57) | |
Capital Expenditures |
(5.51) | (7.23) | (6.66) | (5.86) | |
| Other line items | |||||
Cash ROIC |
15.60% | 15.37% | 9.46% | (23.58%) | |
Accounts Receivable Turnover |
2.16 | 2.12 | 2.21 | 2.82 | |
Accounts Payable Turnover |
11.72 | 11.32 | 12.21 | 17.06 | |
Inventory Turnover |
0.00 | 0.00 | 0.00 | 0.00 | |
Average Days of Payables |
11.61 | 18.15 | 24.11 | 24.85 | |
Days of Inventory on Hand |
0.00 | 0.00 | 0.00 | 0.00 | |
Tax Rate |
(0.25) | 0.05 | 0.07 | 0.09 | |
Research and Development Expense of Revenue |
3.66% | 4.21% | 4.52% | 4.79% | |
Selling, General and Administrative Expense of Revenue |
35.52% | 41.86% | 44.03% | 44.58% | |
Share Based Compensation of Revenue |
4.94% | 5.41% | 5.25% | 4.64% | |
Interest Coverage |
(49.61) | (143.31) | (199.57) | (321.61) | |
Operating CF/Net income |
(1.12) | (0.19) | (0.11) | 0.12 | |
Depreciation/Fixed assets |
1.66 | 5.08 | 5.34 | 5.62 | |
Capex/Depreciation |
(0.23) | (0.10) | (0.09) | (0.08) | |
Revenue per Share |
3.76 | 3.25 | 3.06 | 2.98 | |
Operating CF per Share |
0.59 | 0.35 | 0.21 | (0.23) | |
Capex per Share |
(0.06) | (0.07) | (0.07) | (0.06) | |
Capex to Sales |
0.02 | 0.02 | 0.02 | 0.02 |
Columns are period end dates